The utility of cardiovascular drugs in the treatment of cerebrovascular disease
Cardiovascular and cerebrovascular diseases share many pathophysiological traits, often impact one another and share several risk factors, though not always to the same magnitude. Therefore, it is not surprising that many classes of cardiovascular drugs have demonstrated effectiveness in the primary...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2010
|
| In: |
Current opinion in investigational drugs
Year: 2010, Jahrgang: 11, Heft: 9, Pages: 1015-1024 |
| ISSN: | 2040-3429 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://pubmed.ncbi.nlm.nih.gov/20730696/
|
| Verfasserangaben: | Julian Bösel, Hemasse Amiri |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 183293876X | ||
| 003 | DE-627 | ||
| 005 | 20230710161109.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230201s2010 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)183293876X | ||
| 035 | |a (DE-599)KXP183293876X | ||
| 035 | |a (OCoLC)1389821887 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Bösel, Julian |d 1971- |e VerfasserIn |0 (DE-588)122998294 |0 (DE-627)706122135 |0 (DE-576)293514038 |4 aut | |
| 245 | 1 | 4 | |a The utility of cardiovascular drugs in the treatment of cerebrovascular disease |c Julian Bösel, Hemasse Amiri |
| 264 | 1 | |c 2010 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 01.02.2023 | ||
| 520 | |a Cardiovascular and cerebrovascular diseases share many pathophysiological traits, often impact one another and share several risk factors, though not always to the same magnitude. Therefore, it is not surprising that many classes of cardiovascular drugs have demonstrated effectiveness in the primary prevention, acute treatment and secondary prevention of stroke. Important advances have been made since 2007 in the use of antiplatelets, anticoagulants, antihypertensives, antiarrhythmics and statins for the treatment of stroke. This review summarizes selected clinical trials of cardiovascular drugs completed from 2007 to 2010 that generated important evidence supporting the efficacy of these drugs in stroke treatment. Ongoing trials and preclinical research of promising agents and treatment strategies are also discussed. | ||
| 650 | 4 | |a Anti-Arrhythmia Agents | |
| 650 | 4 | |a Anticoagulants | |
| 650 | 4 | |a Antihypertensive Agents | |
| 650 | 4 | |a Cardiovascular Agents | |
| 650 | 4 | |a Cardiovascular Diseases | |
| 650 | 4 | |a Cerebrovascular Disorders | |
| 650 | 4 | |a Clinical Trials as Topic | |
| 650 | 4 | |a Female | |
| 650 | 4 | |a Humans | |
| 650 | 4 | |a Hydroxymethylglutaryl-CoA Reductase Inhibitors | |
| 650 | 4 | |a Male | |
| 650 | 4 | |a Platelet Aggregation Inhibitors | |
| 650 | 4 | |a Risk Factors | |
| 700 | 1 | |a Amiri, Hemasse |e VerfasserIn |0 (DE-588)1048737306 |0 (DE-627)781215625 |0 (DE-576)403054613 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current opinion in investigational drugs |d London : Biomed Central, 2000 |g 11(2010), 9, Seite 1015-1024 |h Online-Ressource |w (DE-627)37293904X |w (DE-600)2124972-6 |w (DE-576)9372939048 |x 2040-3429 |7 nnas |a The utility of cardiovascular drugs in the treatment of cerebrovascular disease |
| 773 | 1 | 8 | |g volume:11 |g year:2010 |g number:9 |g pages:1015-1024 |g extent:10 |a The utility of cardiovascular drugs in the treatment of cerebrovascular disease |
| 856 | 4 | 0 | |u https://pubmed.ncbi.nlm.nih.gov/20730696/ |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230201 | ||
| 993 | |a Article | ||
| 994 | |a 2010 | ||
| 998 | |g 1048737306 |a Amiri, Hemasse |m 1048737306:Amiri, Hemasse |d 910000 |d 911100 |e 910000PA1048737306 |e 911100PA1048737306 |k 0/910000/ |k 1/910000/911100/ |p 2 |y j | ||
| 998 | |g 122998294 |a Bösel, Julian |m 122998294:Bösel, Julian |d 910000 |d 911100 |e 910000PB122998294 |e 911100PB122998294 |k 0/910000/ |k 1/910000/911100/ |p 1 |x j | ||
| 999 | |a KXP-PPN183293876X |e 4261805111 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 01.02.2023"],"recId":"183293876X","language":["eng"],"title":[{"title":"The utility of cardiovascular drugs in the treatment of cerebrovascular disease","title_sort":"utility of cardiovascular drugs in the treatment of cerebrovascular disease"}],"person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Bösel, Julian","given":"Julian","family":"Bösel"},{"family":"Amiri","given":"Hemasse","display":"Amiri, Hemasse","roleDisplay":"VerfasserIn","role":"aut"}],"physDesc":[{"extent":"10 S."}],"relHost":[{"id":{"issn":["2040-3429"],"zdb":["2124972-6"],"eki":["37293904X"]},"origin":[{"dateIssuedKey":"2000","publisher":"Biomed Central ; Thomson Reuters","dateIssuedDisp":"2000-2010","publisherPlace":"London ; London"}],"title":[{"title":"Current opinion in investigational drugs","title_sort":"Current opinion in investigational drugs"}],"part":{"pages":"1015-1024","issue":"9","year":"2010","extent":"10","volume":"11","text":"11(2010), 9, Seite 1015-1024"},"pubHistory":["1.2000 - 11.2010; damit Ersch. eingest."],"language":["eng"],"recId":"37293904X","physDesc":[{"extent":"Online-Ressource"}],"disp":"The utility of cardiovascular drugs in the treatment of cerebrovascular diseaseCurrent opinion in investigational drugs","type":{"media":"Online-Ressource","bibl":"periodical"}}],"origin":[{"dateIssuedKey":"2010","dateIssuedDisp":"2010"}],"id":{"eki":["183293876X"]},"name":{"displayForm":["Julian Bösel, Hemasse Amiri"]}} | ||
| SRT | |a BOESELJULIUTILITYOFC2010 | ||